IR-Center Handelsblatt
Unternehmenssuche:

Airopack Technology Group AG

News Detail

EQS-Ad-hoc News vom 27.03.2015

Airopack Technology Group AG - ANNUAL REPORT 2014

Airopack Technology Group AG / Key word(s): Final Results

2015-03-27 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.


Airopack Technology Group AG - ANNUAL REPORT 2014 

Baar, March 27, 2015

- 17.9 million pieces of Airopack dispensers shipped to customers in 2014

- Consolidated net sales of EUR 7.2 million, almost 8 times higher than in 2013

- While the annual income statement shows a net loss of EUR 6.1 million, the Group is confident that its operational business will show a significant result improvement in 2015

- Funding of EUR 25.6 million secured to fund Airopack business plan 2015-2016

- Airopack Technology Group provides 2017 financial targets


In 2014, a total of 17.9 million pieces of Airopack dispensers were shipped to customers, compared to 1.4 million pieces in 2013. The majority of the volume was shipped to the globally leading personal care company Procter and Gamble for their shave care brand Gillette Fusion Proglide. On top of volumes shipped to other existing customers like Method Products and Elizabeth Arden, Airopack Group was able to add various new renowned consumer brands such as Aproz, Acure Organics and HAND Chemistry to its sales portfolio in 2014.

On the consolidated level the net sales amounted to EUR 7.2 million, compared to EUR 1.0 million in 2013. The consolidated income statement shows a net loss of EUR 6.1 million. Even though the consolidated EBITDA showed a significant improvement compared to 2013, this was largely off-set by increased depreciation and financing costs.

Funding Airopack business plan
In view of the contracted and expected increase in sales volumes, Airopack will increase its production capacity to 80 million Airopack dispensers per year in 2015 and plans a further increase to 160 million per year in 2016. The required capital expenditure for production equipment, as well as the related working capital needs, are estimated at approximately EUR 25.6 million. Where possible, Airopack will attract external financing such as leasing and factoring. The remainder will be funded from credit facilities committed to the joint venture. To secure the Group's liquidity and the planned investments, the Board of Directors has decided to effect a capital increase which will generate EUR 8.5 million in cash.

Outlook and 2017 financial targets
Based on the contracted and expected increase in sales volumes, Airopack Technology Group expects its 2017 consolidated sales to range between EUR 100m and EUR 130m with a consolidated EBIT-margin of between 13% and 15%.
The 2014 annual report is available for download on the website www.airopackgroup.com under the link - investor relations - reports (http://www.airopackgroup.com/en/investor-relations/reports/).

AIROPACK TECHNOLOGY GROUP AG - KEY FIGURES

  in TEUR in TEUR
  2014 2013
Consolidated income statement    
Net sales 7'210 954
EBITDA -3'474 -4'035
EBIT -5'453 -5'907
Net result -6'050 -6'244
Net result per share in EUR -0.47 -0.54
Consolidated cash flow 508 307
     
Consolidated balance sheet    
Cash and cash equivalents 956 443
Shareholders' equity 4'767 8'774
Balance sheet total 24'722 21'251
 

For more Information:
Airopack Technology Group AG
Frans van der Vorst, CFO
Zugerstrasse 76b
CH-6340 Baar
T: +41 41 766 35 00
E: frans.vandervorst@airopackgroup.com

Airopack Technology Group AG is a leading developer and supplier of mechanical and pressure-controlled dispensing packaging technologies and systems for manufacturers and suppliers of cosmetics, body care, pharmaceutical and food products. The revolutionary and worldwide patented Airopack(R) technology offers a safe, all-plastic pressurized dispenser that is environmentally friendly: no inhalation risks, no propellants and no unnecessary waste. Unlike other pressurized dispensers that use propellants Airopack(R) uses just normal compressed air which results in dispensing a formulation at constant pressure from start to finish.
Airopack Group does not only offer this patented technology but also has a Full-service operation. With this Full-service offering Airopack Group provides a turnkey solution to quickly and easily launch customer products in Airopack(R). Via the unique Full-service operation Airopack Group can mould, assemble, sleeve or label, fill and pack Airopack(R) to customer's specifications. In addition Airopack Group has a highly experienced laboratory for formulation development and bulk production to ensure the best quality and control.
Within the context of a joint venture (Airolux AG) with Resilux (www.resilux.com) the Airopack Technology Group operates a manufacturing facility in Glarus Nord, Switzerland, a Full-service operation in Belgiium, a PCD production operation, global R&D and customer service facility in Waalwijk, the Netherlands and a sales office in Pendergrass, Georgia, United States of America. With deliveries to the world's largest and leading consumer brands, Airopack Technology Group reached a key milestone in 2015 with respect to commercial market entry. The shares of the company are listed on the Domestic Standard of the SIX Swiss Exchange since 2010. (Ticker: AIRN / ISIN: CH0242606942).
 

Airopack Technology Group AG
Frans van der Vorst, CFO
Zugerstrasse 76b
CH-6340 Baar
T +41 41 766 35 00
E frans.vandervorst@airopackgroup.com
 
www.airopackgroup.com

End of ad hoc announcement


2015-03-27 News transmitted by EQS Schweiz AG. www.eqs.com - news archive: http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release.



338259  2015-03-27